NCAM1 and neoplasm: Furthermore, in the whole cohort, patients with tumours displaying a high CD56+ NK/NK T cell ratio who received no adjuvant chemotherapy had a more favourable prognosis than patients with a low CD56+ NK/NK T cell ratio who received adjuvant chemotherapy.